Professor Marcin Barczynski
Dr Marcin Barczynski was trained in Poland, Germany and USA and has more than 20 years of experience in general surgery, endocrine surgery and surgical oncology. He is a full Professor of Surgery at the Jagiellonian University, Medical College, Department of Endocrine Surgery in Krakow, Poland.Dr Barczynski has a busy thyroid, parathyroid and adrenal surgical practice, seeing and operating on patients both in public and private sector. Dr Barczynski currently serves as President-Elect of the European Society of Endocrine Surgeons (ESES), Chairman of the EUROCRINE Society, a member of the Steering Committee of the International Neural Monitoring Study Group (INMSG) for Thyroid and Parathyroid Surgery and Secretary of the UEMS Division of Endocrine Surgery of the European Board of Surgery. Dr Barczynski is an active member of numerous scientific societies, including the European Surgical Association (ESA), European Thyroid Association (ETA), International Association of Endocrine Surgeons (IAES), and American Association of Endocrine Surgeons (AAES). He is the author of more than 180 peer-reviewed publications and book chapters and serves on many editorial boards. His citation index is equal to 2432, and h-index is 27. His work in improving surgical outcomes, nerve monitoring and exploring novel treatment techniques for thyroid, parathyroid, and adrenal diseases has helped the medical field tailor and personalise treatment for patients with these conditions.
Professor Stan Sidhu
Stan Sidhu is Professor of Surgery and Head of the University of Sydney Endocrine Surgical Unit. This Unit has been in operation for more than 50 years based at Royal North Shore Hospital. He performs more
than 500 thyroidectomies, parathyroidectomies and adrenalectomies per year specialising in large goitres, papillary and medullary thyroid cancer surgery, neck dissection, minimally invasive parathyroidectomy, redo parathyroid surgery and endoscopic or keyhole adrenalectomy. Professor Sidhu has published a number of clinical outcome studies in thyroidectomy, parathyroidectomy and adrenalectomy and in addition to his clinical load, he is an active translational cancer researcher with projects involving the use of non-coding RNA as biomarkers of diagnosis, prognosis and therapeutic effect in thyroid and adrenal malignancy. He is a senior researcher in the Cancer genetics laboratory of the Kolling Institute at Royal North Shore Hospital and is actively involved in research with the biotechnology company EngeneIC delivering non-coding RNA for the treatment of patients with metastatic endocrine malignancy. Professor Sidhu supervises a number of Clinical Fellows and Doctoral students at the Kolling Institute of Medical Research and is immediate Past President of ANZES and Councillor of the International Association of Endocrine Surgeons.
Associate Professor Carrie Lubitz
Carrie C. Lubitz, MD, MPH, is an Associate Professor of Surgery at Harvard Medical School, Endocrine Surgeon in the Division of Surgical Oncology at Massachusetts General Hospital (MGH) and a Senior Scientist at the MGH Institute of Technology Assessment. In addition to her clinical endocrine surgery practice, Dr Lubitz leads a research program focused on appropriateness of care and patient-reported outcome measurement. She is a current principal investigator of an R37 (R01 equivalent) from the National Institute of Health/National Cancer Institute for her health-service and translational research interests including decision-analytic modeling to assess the comparative effectiveness and improve the quality of care of patients with thyroid cancer. Additionally, she is the Recorder of the Association of Academic Surgery, the program committee chair of American Association of Endocrine Surgeons and a member of the American Thyroid Association Surgical Task Force. (In association with the Section of Academic Surgery).